Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Bacteriophages in Acne Care: A New JDD Study to Watch This is a must-read article from JDD for dermatology professionals following the search for new acne treatments. A randomized, double-blind,…
New Review Highlights How Dermatologists May Better Identify cSCC Patients Who Benefit From Adjuvant Radiation Have you read this article from the JDD? A new systematic review is drawing attention to…
Rosacea Conversations Are Exploding Online, and This JDD Article Breaks It Down If you treat rosacea, this JDD article is a must read. A new cross-sectional analysis of the r/Rosacea…
Wound Care Is Trending: A JDD Vault Pick on Bensal HP and Repair This is a must-read article from JDD. Wound care is a hot topic in dermatology and that is…
The U.S. Food & Drug Administration (FDA) recently adopted changes to the approvals of two medications for inflammatory skin diseases. Ebglyss (lebrikizumab-lbkz) has a newly approved regimen of one maintenance…